Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H21NO3 |
| Molecular Weight | 251.3214 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCC(O)C1=CC=CC(OC(=O)C(C)(C)C)=C1
InChI
InChIKey=DQCAWJLMFJKICG-UHFFFAOYSA-N
InChI=1S/C14H21NO3/c1-14(2,3)13(17)18-11-7-5-6-10(8-11)12(16)9-15-4/h5-8,12,15-16H,9H2,1-4H3
| Molecular Formula | C14H21NO3 |
| Molecular Weight | 251.3214 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Pivenfrine is a sympathomimetic agent. Pivenfrine is an analog of phenylephrine hydrochloride (PE) ten times more potent as a mydriatic. It is a product of the esterification of a molecule of pivalic acid (PA) to the p-hydroxyl group of PE. It is, therefore, more lipophilic than PE is, and penetrates the cornea more readily. Pivenfrine is called a prodrug of PE because it is enzymatically hydrolyzed to the active, parent compound (PE), and to PA, before reaching its desired active site in the eye. The pivenfrine-treated corneas without epithelium significantly increased in thickness, whereas no change in thickness was observed in corneas with epithelium intact.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:21:10 GMT 2025
by
admin
on
Mon Mar 31 18:21:10 GMT 2025
|
| Record UNII |
RB4XQ0T71U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29747
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081705
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
RB4XQ0T71U
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107163
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
DTXSID80867279
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
130545
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
SUB09950MIG
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
C66442
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
67577-23-5
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
4630
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY | |||
|
Pivenfrine
Created by
admin on Mon Mar 31 18:21:10 GMT 2025 , Edited by admin on Mon Mar 31 18:21:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |